The Glucose Tolerance Test (GTT) is a diagnostic medical investigation used to assess how the body clears a standard glucose load from the bloodstream. While a fasting blood sugar measurement captures a single snapshot, the GTT evaluates metabolic dynamics over a sustained period. It uncovers how efficiently pancreatic insulin production matches rising blood glucose levels. This makes it particularly valuable when routine screening tests yield borderline results or when clinical suspicion of disordered carbohydrate metabolism remains high despite normal fasting values.
Healthcare providers order the GTT primarily to diagnose gestational diabetes mellitus in pregnant women, typically between the 24th and 28th weeks of gestation. It is also indicated for non-pregnant individuals showing symptoms of prediabetes, unexplained reactive hypoglycemia, or impaired glucose tolerance when fasting blood tests are inconclusive. Routine screening is generally avoided in patients with established, diagnosed diabetes mellitus, as administering a heavy glucose load to them is clinically unnecessary and potentially dangerous.
Accurate test results depend heavily on proper pre-procedure preparation. Nurses must instruct the client to maintain an unrestricted carbohydrate diet containing at least 150 grams of carbohydrates daily for three days before the test. Low-carbohydrate diets can falsely impair glucose tolerance.
Interpretation relies on comparing blood glucose levels against established threshold values at specific time intervals. For a standard 75-gram two-hour oral glucose tolerance test in non-pregnant adults, a fasting plasma glucose below 5.6 mmol/L (100 mg/dL) and a two-hour level below 7.8 mmol/L (140 mg/dL) are considered normal. Values between 7.8 and 11.0 mmol/L at two hours indicate impaired glucose tolerance, while levels at or above 11.1 mmol/L (200 mg/dL) at two hours strongly point toward a diagnosis of diabetes mellitus. Gestational criteria use different, stricter threshold limits determined by specific obstetric guidelines.
Numerous physiological and environmental variables can distort GTT results, leading to misdiagnosis. Acute illness, infection, or surgical stress triggers the release of cortisol and adrenaline, raising blood glucose independently. Prolonged bed rest or physical inactivity decreases insulin sensitivity. Gastrointestinal disorders that alter gastric emptying rates can delay or accelerate glucose absorption, producing erratic blood curves. Additionally, smoking during the testing window introduces nicotine, which stimulates glycogenolysis and skews the data.
Once the final blood sample is collected, nursing responsibilities shift toward physical recovery and stabilization. The nurse should immediately offer the client a substantial meal and encourage fluid intake, as fasting combined with serial blood draws often causes fatigue, dizziness, or orthostatic hypotension. Clients should be monitored for delayed reactive hypoglycemia, which can occur several hours after the concentrated glucose load. Documenting the client's tolerance, noting any adverse reactions during the procedure, and ensuring prompt labeling and transport of laboratory specimens complete the nursing care protocol.
The concentrated glucose solution frequently provokes gastrointestinal side effects. Nausea, abdominal cramping, and vomiting are common, especially when the drink is consumed rapidly on an empty stomach. If a client vomits the glucose solution, the test must be stopped and rescheduled for another day, as the exact ingested dose is no longer known. Vasovagal episodes, dizziness, and fainting can also occur due to prolonged fasting and repeated venipuncture; the nurse must ensure the client remains seated in a comfortable chair and report any severe distress immediately.